Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × FED × Capecitabine × Clear all

Phase

Phase 4 1 Phase 1 1

Status

Sponsor Class

OTHER 111 INDUSTRY 65 NIH 12 NETWORK 5 UNKNOWN 2 OTHER_GOV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1

Interventions

sargramostim 1 pembrolizumab 1 Injections 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Exercise 1 Cryotherapy 1 Cryosurgery 1 Clofarabine 1 Celecoxib 1 Capecitabine 1 ADI PEG20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00216437 2007-11-12

Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma

James A. Haley Veterans Administration Hospital

Phase 1 Terminated

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡